1. Home
  2. DVA vs MORN Comparison

DVA vs MORN Comparison

Compare DVA & MORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DVA
  • MORN
  • Stock Information
  • Founded
  • DVA 1994
  • MORN 1984
  • Country
  • DVA United States
  • MORN United States
  • Employees
  • DVA N/A
  • MORN N/A
  • Industry
  • DVA Misc Health and Biotechnology Services
  • MORN Investment Managers
  • Sector
  • DVA Health Care
  • MORN Finance
  • Exchange
  • DVA Nasdaq
  • MORN Nasdaq
  • Market Cap
  • DVA 9.4B
  • MORN 9.0B
  • IPO Year
  • DVA 1995
  • MORN 2005
  • Fundamental
  • Price
  • DVA $119.57
  • MORN $209.89
  • Analyst Decision
  • DVA Hold
  • MORN Strong Buy
  • Analyst Count
  • DVA 4
  • MORN 3
  • Target Price
  • DVA $145.00
  • MORN $333.33
  • AVG Volume (30 Days)
  • DVA 957.9K
  • MORN 409.6K
  • Earning Date
  • DVA 10-29-2025
  • MORN 10-29-2025
  • Dividend Yield
  • DVA N/A
  • MORN 0.86%
  • EPS Growth
  • DVA 5.63
  • MORN 16.18
  • EPS
  • DVA 9.76
  • MORN 8.80
  • Revenue
  • DVA $13,317,965,000.00
  • MORN $2,395,400,000.00
  • Revenue This Year
  • DVA $6.24
  • MORN $8.52
  • Revenue Next Year
  • DVA $3.32
  • MORN $7.45
  • P/E Ratio
  • DVA $12.45
  • MORN $24.10
  • Revenue Growth
  • DVA 5.14
  • MORN 7.76
  • 52 Week Low
  • DVA $115.39
  • MORN $202.89
  • 52 Week High
  • DVA $179.60
  • MORN $365.00
  • Technical
  • Relative Strength Index (RSI)
  • DVA 38.97
  • MORN 37.22
  • Support Level
  • DVA $118.75
  • MORN $206.68
  • Resistance Level
  • DVA $125.68
  • MORN $217.20
  • Average True Range (ATR)
  • DVA 3.56
  • MORN 5.36
  • MACD
  • DVA 0.10
  • MORN 0.71
  • Stochastic Oscillator
  • DVA 27.51
  • MORN 45.06

About DVA DaVita Inc.

DaVita is the largest provider of dialysis services in the United States, boasting market share of about 35% when measured by clinics. The firm operates over 3,000 facilities worldwide, mostly in the US, and treats about 280,000 patients globally each year. Government payers dominate US dialysis reimbursement. DaVita receives about two thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business. Berkshire Hathaway owns about 45% of DaVita.

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

Share on Social Networks: